Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms JPX-750 |
Action inhibitors |
Mechanism STAT5 transcription factor inhibitors(STAT5 transcription factor inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | United States | 15 Aug 2020 | |
Acute Myeloid Leukemia | Preclinical | Canada | 15 Aug 2020 | |
Acute Myeloid Leukemia | Preclinical | Canada | 15 Aug 2020 |